381 related articles for article (PubMed ID: 22733553)
1. Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectives.
Saunders NA; Simpson F; Thompson EW; Hill MM; Endo-Munoz L; Leggatt G; Minchin RF; Guminski A
EMBO Mol Med; 2012 Aug; 4(8):675-84. PubMed ID: 22733553
[TBL] [Abstract][Full Text] [Related]
2. Not Everyone Fits the Mold: Intratumor and Intertumor Heterogeneity and Innovative Cancer Drug Design and Development.
Dzobo K; Senthebane DA; Thomford NE; Rowe A; Dandara C; Parker MI
OMICS; 2018 Jan; 22(1):17-34. PubMed ID: 29356626
[TBL] [Abstract][Full Text] [Related]
3. Taking advantage of drug resistance, a new approach in the war on cancer.
Wang L; Bernards R
Front Med; 2018 Aug; 12(4):490-495. PubMed ID: 30022460
[TBL] [Abstract][Full Text] [Related]
4. The multi-factorial nature of clinical multidrug resistance in cancer.
Assaraf YG; Brozovic A; Gonçalves AC; Jurkovicova D; Linē A; Machuqueiro M; Saponara S; Sarmento-Ribeiro AB; Xavier CPR; Vasconcelos MH
Drug Resist Updat; 2019 Sep; 46():100645. PubMed ID: 31585396
[TBL] [Abstract][Full Text] [Related]
5. Amino Acid Metabolism in Cancer Drug Resistance.
Yoo HC; Han JM
Cells; 2022 Jan; 11(1):. PubMed ID: 35011702
[TBL] [Abstract][Full Text] [Related]
6. EMT, CSCs, and drug resistance: the mechanistic link and clinical implications.
Shibue T; Weinberg RA
Nat Rev Clin Oncol; 2017 Oct; 14(10):611-629. PubMed ID: 28397828
[TBL] [Abstract][Full Text] [Related]
7. Tumour microenvironment on mitochondrial dynamics and chemoresistance in cancer.
Han Y; Cho U; Kim S; Park IS; Cho JH; Dhanasekaran DN; Song YS
Free Radic Res; 2018 Dec; 52(11-12):1271-1287. PubMed ID: 29607684
[TBL] [Abstract][Full Text] [Related]
8. Tumour heterogeneity and resistance to cancer therapies.
Dagogo-Jack I; Shaw AT
Nat Rev Clin Oncol; 2018 Feb; 15(2):81-94. PubMed ID: 29115304
[TBL] [Abstract][Full Text] [Related]
9. Tumour heterogeneity and the evolution of polyclonal drug resistance.
Burrell RA; Swanton C
Mol Oncol; 2014 Sep; 8(6):1095-111. PubMed ID: 25087573
[TBL] [Abstract][Full Text] [Related]
10. Spatial heterogeneity in drug concentrations can facilitate the emergence of resistance to cancer therapy.
Fu F; Nowak MA; Bonhoeffer S
PLoS Comput Biol; 2015 Mar; 11(3):e1004142. PubMed ID: 25789469
[TBL] [Abstract][Full Text] [Related]
11. Genotype- or Phenotype-Targeting Anticancer Therapies? Lessons from Tumor Evolutionary Biology.
Escargueil AE; Prado S; Dezaire A; Clairambault J; Larsen AK; Soares DG
Curr Pharm Des; 2016; 22(44):6625-6644. PubMed ID: 27587198
[TBL] [Abstract][Full Text] [Related]
12. [Tumor heterogeneity and drug resistance of targeted antitumor agents].
He QY
Yao Xue Xue Bao; 2016 Feb; 51(2):197-201. PubMed ID: 29856199
[TBL] [Abstract][Full Text] [Related]
13. Addressing intra-tumoral heterogeneity and therapy resistance.
Rybinski B; Yun K
Oncotarget; 2016 Nov; 7(44):72322-72342. PubMed ID: 27608848
[TBL] [Abstract][Full Text] [Related]
14. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
Shapira A; Livney YD; Broxterman HJ; Assaraf YG
Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
[TBL] [Abstract][Full Text] [Related]
15. Insights into new mechanisms and models of cancer stem cell multidrug resistance.
Garcia-Mayea Y; Mir C; Masson F; Paciucci R; LLeonart ME
Semin Cancer Biol; 2020 Feb; 60():166-180. PubMed ID: 31369817
[TBL] [Abstract][Full Text] [Related]
16. Tolerant/Persister Cancer Cells and the Path to Resistance to Targeted Therapy.
Swayden M; Chhouri H; Anouar Y; Grumolato L
Cells; 2020 Dec; 9(12):. PubMed ID: 33291749
[TBL] [Abstract][Full Text] [Related]
17. Intratumoural Heterogeneity Underlies Distinct Therapy Responses and Treatment Resistance in Glioblastoma.
Akgül S; Patch AM; D'Souza RCJ; Mukhopadhyay P; Nones K; Kempe S; Kazakoff SH; Jeffree RL; Stringer BW; Pearson JV; Waddell N; Day BW
Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30736342
[TBL] [Abstract][Full Text] [Related]
18. The pharmacological point of view of resistance to therapy in tumors.
Damia G; Garattini S
Cancer Treat Rev; 2014 Sep; 40(8):909-16. PubMed ID: 24969326
[TBL] [Abstract][Full Text] [Related]
19. Cell Culture System for Analysis of Genetic Heterogeneity Within Hepatocellular Carcinomas and Response to Pharmacologic Agents.
Gao Q; Wang ZC; Duan M; Lin YH; Zhou XY; Worthley DL; Wang XY; Niu G; Xia Y; Deng M; Liu LZ; Shi JY; Yang LX; Zhang S; Ding ZB; Zhou J; Liang CM; Cao Y; Xiong L; Xi R; Shi YY; Fan J
Gastroenterology; 2017 Jan; 152(1):232-242.e4. PubMed ID: 27639803
[TBL] [Abstract][Full Text] [Related]
20. The role of memory in non-genetic inheritance and its impact on cancer treatment resistance.
Cassidy T; Nichol D; Robertson-Tessi M; Craig M; Anderson ARA
PLoS Comput Biol; 2021 Aug; 17(8):e1009348. PubMed ID: 34460809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
